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Abstract
The purpose of this demonstration project was to assess the compliance of crew members to a portion
of the exercise countermeasures planned for use during stays onboard the International Space Station
(ISS) and to assess the outcomes of performing these countermeasures. Although these countermea-
sures have been used separately in other projects and investigations, this was the first time they had
been used together for an extended period of time (60 days) in an investigation of this nature. Crew
members exercised every day for six days, alternating every other day between aerobic and resistive
exercise, and rested on the seventh day. On the aerobic exercise days, subjects exercised on an
electronically braked cycle ergometer using a protocol which has been previously shown to maintain
aerobic capacity in subjects exposed to a spaceflight analogue (6 ° head-down tilt bed rest). On the
resistive exercise days, crew members performed five major multi-joint resistive exercises--bench
press, seated press, lat pull, squats, and heel raises--in a concentric mode, targeting those muscle
groups and bones which are believed to be most severely affected by spaceflight. Subjects performed
maximal efforts with each repetition. Both exercise protocols were well tolerated by the subjects,
demonstrated by a 98% compliance to aerobic exercise prescription and a 91% adherence to the
resistive exercise protocol. Subjects also reported favorable comments. After 60 days, the crew
members improved their peak aerobic capacity by an average of 7%. Strength gains during bench
press, shoulder press, lat pull, heel raise, and squat exercises were noted in all subjects. The results of
this investigation suggest that these aerobic and resistive exercise protocols can be performed during
an ISS, lunar, or Mars mission. However, more frequent bouts of both resistive and aerobic exercise
are anticipated to be required to maintain crew health during long-duration spaceflight. Future
projects should investigate the impact of increased exercise duration and frequency on the
compliance of subjects and the efficacy of such exercise prescriptions.
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I. Introduction
A. Lunar-Mars Life Support Test Project (LMLSTP) Objectives
The LMLSTP Phase IIA was the third in a series of four life support system technology investigations
by the Crew and Thermal Systems Division (CTSD) at Johnson Space Center (JSC). Previous ex-
perimental projects have included a 15-day chamber test (Phase I) in which plants provided the air
revitalization for a single subject and a 30-day chamber test (Phase II) in which an integrated
regenerative life support system was demonstrated with four humans in a closed chamber (Figure 1).
This chamber, the Life Support Systems Integration Facility, was also used during Phase IIA. Phase
IIA was a 60-day demonstration of life support technologies, the air revitalization system and the
water recovery system, intended for use onboard the International Space Station (ISS) [13]. During
this test, investigators and medical support personnel from the Medical Sciences Division, including
the Exercise Physiology Laboratory (EXL), were invited to evaluate their planned protocols for ISS.
Figure 1. Life Support Systems Integration Facility.
B. Exercise Countermeasures Demonstration Project Objectives
The Exercise Countermeasures Demonstration Project had two objectives:
• Examine the efficacy of exercise testing and prescription methods planned for use in the
development of exercise countermeasures onboard ISS.
• Provide realistic perturbations of the carbon dioxide production and oxygen utilization as
anticipated onboard ISS to challenge the environmental control systems.
Specifically,this demonstrationprojectsoughtto providedatain four areas:
• the qualityof informationprovidedby thepre-andin-chambertestingprotocolsfor the
assessmentof crewhealth
• thetrainingeffectsprovidedby long-termperformanceof theplannedexercisecountermeasures
• thetoleranceof subjectsto boththeaerobicandtheresistiveexercisecountermeasures
• themethodsplannedto documenttheperformanceof theexercisecountermeasures
Further,theperformancesof theseexercisecountermeasureswereusedto manipulatetheconditions
within thechambersuchthattheperformancesof theenvironmentalcontrolsystemscouldbe
assessedin their ability to correctundesiredchangesin ambientgasconcentrations.In previous
chambertesting,crewmemberexercisewasfoundto significantlyincreaseambientcarbondioxide
concentrations[13].
C. Protocol Overview
CTSD selected eight subjects for participation in this study based upon their familiarity with
operation of the chamber environmental systems and/or their ability to perform specific required
tasks. Four individuals, three males and one female, were chosen to be prime crew members. The
remaining four subjects served as backups in case one or more of the prime crew members were
disqualified from participation before entering the chamber. Subjects were screened for participation
using a modified Air Force Class III Physical and a modified Cunningham treadmill exercise
protocol. These tests were administered by the JSC Flight Medicine Clinic. Prime crew members,
three males and one female, were 31+4 years, 175+5 cm, and 70.4+10.9 kg. Backup crew members,
also three males and one female, were 32+5 years, 173+5 cm, and 62.7+9.7 kg.
Subjects received written and verbal explanation of the procedures specific to the exercise counter-
measures demonstration project and signed written consent confirming their understanding and
acceptance.
All eight subjects participated in the pre-chamber testing. Pre-chamber testing included a graded
cycle ergometer test to volitional fatigue, submaximal cycle ergometer exercise tests, resting
metabolic rate measures, and a validation session of the aerobic exercise countermeasure. Subjects
also received two training sessions on the resistive exercise countermeasure device.
Only the prime crew members participated in exercise training and testing after the pre-chamber
testing was complete. During the chamber test, on alternate days the crew members completed the
aerobic and the resistive countermeasures three times per week. In several instances, exercise was
delayed or cancelled due to malfunction of environmental control systems. Three times during the
60-day period----on days 15, 30, and 58--crew members completed the submaximal exercise test in
place of the aerobic exercise training. At the conclusion of the chamber test, the four prime crew
members returned to the EXL for a graded cycle ergometer test to volitional fatigue.
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II. Exercise Testing Methods and Results of Pre-Chamber Tests
The aerobic exercise testing protocols chosen for this investigation were those proposed for use in the
Space Medicine Project (SMP) on ISS as a means to monitor crew health. This investigation served as
a test bed, or practice session, for these testing protocols. Data included in this section are from all
eight subjects, prime and backup, and are intended to indicate expected results for a larger popula-
tion. Data specific to the prime crew are presented in Chapter IV, "LMLSTP Phase IIA Data and
Results."
No resistive exercise testing was performed in the pre-chamber phase of the LMLSTP IIA program.
A. Peak Aerobic Exercise Test
Subjects completed a maximal exercise test to quantify their individual fitness levels and to aid in the
prescription of the exercise countermeasure and the submaximal exercise test. Subjects pedaled on
an electronically braked cycle ergometer in the upright position at a constant pedaling cadence of 75
rpm. Expired gases were collected and analyzed using a Quinton Qplex Metabolic Cart (Quinton
Industries, Seattle, WA) interfaced with a mass spectrometer (MG-1100, Marquette, Inc., Minneapolis,
MN). Heart rate was monitored using a three-lead ECG configuration (Quinton Q5000 Stress Test
System, Quinton Industries, Seattle, WA).
The maximal exercise test began with three 3-minute stages of increasing workloads (Figure 2). For
male subjects, these workloads were 50, 100, and 150 watts. Female subjects completed workloads of
50, 75, and 100 watts. Thereafter, for both subject groups the workload was increased in 25-watt
increments each minute until volitional fatigue. Peak oxygen consumption (VO2pk) was accepted as
the mean of the last two 30-second measurements of oxygen consumption (VO2). Heart rate (HR)
was recorded in the last 15 seconds of each minute, and rating of perceived exertion (RPE; Borg's
revised 10-point scale) [9] was recorded in the last 20 seconds of each stage. Blood pressure was
measured manually by the auscultatory method in the last 30 seconds of each 3-minute stage.
I Workload 1
3 min
I Workload 2
3 rain
To Volitional
Fatigue
I 25 Watt IncrementsWorkload 3 1 min
3 min
Figure 2. Peak aerobic exercise test protocol
Subjects (n=8) completed a mean (±SD) workload of 225+44 watts with a total test time of 12.6+1.1
minutes. The mean peak absolute oxygen consumption was 2.67+0.58 L/min, or expressed relative
to body weight, 40.3+4.9 mL/kg/min. Heart rate at the peak exercise intensity was 186±6 bpm, and
the peak RPE was 8±2.
B. Submaximal Aerobic Exercise Test
The submaximal cycle exercise test was individually prescribed for each subject according to their
performance in the VO2pk exercise test. Subjects completed three 5-minute exercise intensities of
25%, 50%, and 75% of VO2pk (Figure 3) on the same electronically braked upright cycle ergometer.
Subjects recovered by cycling for five minutes at 25% of VO2pk. The pedaling cadence was
maintained at 75 rpm. Expired gases were collected as the subjects exercised using a Quinton Qplex
Metabolic Cart interfaced with a mass spectrometer. Heart rate was measured using a heart rate
monitor (Polar Vantage XL, Polar, Inc., Stamford, CN), previously validated in our laboratory [12].
Heart rate data were saved in 15-second intervals. The mean VO2 and HR for each stage of this
submaximal exercise test were calculated.
I
5 min 5 min
75% VO2pk
5 min
50% VO2pk
5 min
Figure 3. Submaximal aerobic exercise test protocol.
The exercise intensities (n=8) at 25, 50, and 75% of VO2pk were equivalent to mean (±SD) power
outputs of 23±11, 87_+22, and 151±32 watts, respectively. Mean VO2 at these exercise intensities
were 0.76±0.16 L/min (11.3±1.4 mL/kg/min), 1.40+0.19 L/min (20.8+2.7 mL/kg/min), and
2.25±0.46 L/min (33.6±4.4 mL/kg/min). The mean HRs were 95±6, 124±8, and 164+_8 bpm, and the
mean RPEs were 1+0, 3±0, and 5±1.
The differences between the actual VO2 at each exercise intensity and those predicted from data from
the VO2pk test were 0.09±0.4, 0.06±0.04, and 0.25±0.10 L/rain. The differences between the actual
HR at each exercise intensity and those predicted from data from the VO2pk test were 3+10, 1+8, and
8+9 bpm.
C. Muscle Strength and Endurance Assessment
The planned testing protocols for the ISS crew members include isokinetic exercise testing of the
knee, back, and ankle. Due to the limited time available for testing before entering the chamber,
these tests were not performed for this demonstration project. Future demonstration projects with
CTSD will incorporate these muscle strength and endurance assessments.
The efficacy of the resistive exercise countermeasure protocol was assessed in this project by exam-
ining the daily resistive exercise records for each subject. These data and analyses are presented in
Chapter IV, Section B, "LMLSTP Phase IIA Data and Results: Resistive Exercise Countermeasure."
D. Metabolic Calibrations
Although not a test for ISS, CTSD requested metabolic calibrations of each crew member who would
potentially be entered into the chamber study. The purpose of this data collection was to provide
information regarding the expected loads on the environmental control systems. Metabolic meas-
urements were made during supine and seated rest, the aerobic exercise countermeasure, and the
submaximal aerobic exercise tests.
Subjects (n=8) were tested at rest in both the supine and seated positions. Subjects were fitted with a
face mask with a one-way, non-rebreathing valve (Hans Rudolph, Inc., Kansas City, MO) for the
collection of expired gases, and rested quietly in the supine position for a period of at least 20
minutes. During this time, expired gases were collected in a 120-liter gasometer (Warren E. Collins,
Inc., Braintree, MA) in 5-minute increments and subsequently expelled to wash out the room air in
the tank. Thereafter, three successive 5-minute collections of expired gases were collected in the
gasometer. The volume of each sample was determined, and the relative concentrations of oxygen
and carbon dioxide were measured using a mass spectrometer. Subjects moved to the seated posture
for at least 5 minutes before three additional 5-minute data collections were repeated in the seated
posture. Oxygen consumption and carbon dioxide production were calculated [7] for each 5-minute
period. The data from each of the three samples for each posture were averaged and accepted as
representative of that posture. Respiratory water production was calculated during supine and seated
rest and during the exercise countermeasure using the equation:
Me = 0.019 x VO2 x (44-Pa),
where Me is the rate of respiratory water loss (g/min), VO2 is the oxygen uptake of the subject
(L/min), and Pa is ambient water vapor pressure (mmHg) [10].
Data from the pre-chamber aerobic exercise countermeasure and the submaximal exercise tests were
collected during the normal testing procedures and were expressed as the mean oxygen consumption,
carbon dioxide production, and water vapor production per minute across the entire exercise period.
Table 1. Metabolic Calibration Data (n=8)
VO2
(L/rain)
VO2
(mL/kg/min)
VCO2
(L/min)
Me
(g/min)
Supine Rest 0.22+0.03 3.34+0.34 0.19+0.03 0.15+0.02
Seated Rest 0.23+0.03 3.44+0.29 0.19+0.02 0.15+0.02
Exercise Countermeasure 1.59+0.33 23.83+2.99 1.62+0.36 1.06+0.22
Submaximal Test 1.37+0.29 20.30+2.64 1.39+0,30 0.87+0.19
Data for the prime crew are presented in Chapter IV, Section E, "LMLSTP Phase IIA Data and
Results: Metabolic Calibrations."
III. Exercise Countermeasure Methods and Results of
Pre-Chamber Tests
The aerobic exercise countermeasure protocol chosen for this investigation is similar to that proposed
for use in the SMP on ISS as a means to maintain crew health. This investigation served as a test bed,
or practice session, for this countermeasure protocol. Data included in this section are from all eight
subjects, prime and backup, and are intended to indicate expected results for a larger population.
Data specific to the prime crew are presented in Chapter IV, Section C, "LMLSTP Phase IIA Data
and Results: Maximal Aerobic Exercise Test Results," and Chapter IV, Section D, "LMLSTP Phase
IIA Data and Results: Submaximal Aerobic Exercise Test Results."
The resistive exercise countermeasure protocol was designed to be similar to the exercise protocol
under development for ISS. Data collected during the resistive exercise training are presented in
Chapter IV, Section B, "LMLSTP Phase IIA Data and Results: Resistive Exercise Countermeasure."
No data on pre-chamber resistive exercise familiarization training are presented here.
A. Aerobic Exercise Countermeasure
Based upon the results of the VO2pk exercise test, an aerobic exercise countermeasure which has
been previously used to maintain exercise capacity in bed rest subjects [2, 3, 5] was prescribed. The
exercise protocol is shown in Figure 4. The exercise began with a warm-up period of seven minutes
at an exercise intensity equivalent to 40% of VO2pk. Thereafter, the exercise intensity alternated in
2-minute intervals between 40% VO2pk and 60%, 70%, 80%, 90%, and 80% VO2pk. This interval
training period was then followed by 5 minutes of exercising cool-down at 40% VO2pk.
Warm-up
(40%)
7 min
80%
70%
I
90%
1
1
80%
Cool-Down
(40%)
5 min
2 min intervals
Figure 4. Aerobic exercise countermeasure protocol.
Subjects completed the exercise protocol in the EXL and were monitored for VO2 and carbon
dioxide production using a Quinton Qplex Metabolic Cart interfaced with a mass spectrometer. Heart
rate was measured using a heart rate monitor. The mean (+SD) VO2 and HR (Figure 5) for each
stage of this exercise countermeasure were calculated.
The mean difference across all subjects between actual VO2 and the VO2 predicted by the data from
the VO2pk exercise test was not greater than 0.11 L/min for an individual exercise intensity.
Similarly, the mean difference across all subjects between actual HR and the HR predicted by the data
from the maximal exercise test was not greater than 4 bpm for an individual exercise intensity.
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B. Resistance Exercise Countermeasure
Data from this laboratory and others suggest that high-intensity resistive exercise may assist in the
maintenance of muscle and strength [1] and of bone density [4]. The protocol used in this demon-
stration project was a whole body resistive exercise protocol similar to one previously demonstrated to
increase muscle mass, muscle strength, and bone density after 10 weeks of training in ambulatory
subjects [8].
In this demonstration project, crew members trained isokinetically three days per week for a total of
9 weeks on a computer-controlled resistive exercise device. The Computerized Exercise System
(CES) by Ariel Life Systems, Inc. (San Diego, CA), consists of a single, multifunction exercise station,
using passive hydraulic resistance, integrated with a laptop computer. This multifunction station
allows for the performance of several multi-joint exercises. In this demonstration project, subjects
performed bench press, seated shoulder press, lat pull, squats, and heel raises. All training was in the
concentric mode. Crew members were familiarized with the CES before entering the chamber and
were instructed on proper exercise form.
Throughout the study, subjects performed four sets of each exercise, one warm-up set at approxi-
mately 50% of their maximum effort followed by three sets of maximal effort with each repetition.
The first week of resistance training in the chamber was treated as a familiarization period. Each day
of the first week, crew members performed four sets of 10 repetitions of each exercise at 40°/sec with
the exception of the heel raise which was performed at 15°/sec. From weeks 2 to 9, crew members
performed a mini-periodization of resistance exercise within each week. The number of sets was
maintained at four throughout, one warm-up and three maximal effort, but the velocity of movement,
number of repetitions per set, and amount of muscle tension developed varied across the week (Table
2). On the first day of resistance training within the week, the bench press, lat pull, seated shoulder
press, and squats were performed at a slow speed (LO) of 20°/sec for six repetitions per set. The
second day of training was performed at the fastest speed (HI) of 50°/sec for 12 repetitions, and the
third day was performed at a moderate speed (MED) of 35°/sec for eight repetitions. Crew members
performed the same number of repetitions for the heel raises as the other exercise, but the velocities
of movementwere10°/secon LO, 15°/sec on MED, and 20°/sec on HI. In this way, by performing
maximal efforts with each repetition on each day, the subjects generated the greatest muscle forces on
the first day (LO) during the slow speed of movement, the least muscle tension on the second day
(HI) during the fastest movement speed, and a moderate amount of muscle tension during moderate
movement speed (MED).
Table 2. Movement Velocity and Repetitions for Each Resistive Exercise Day
Movement Calf Raise Others
Speed Speed (°/sec) Repetitions Speed (°/sec) Repetitions
LO 10 6 20 6
MED 15 8 35 8
HI 20 12 50 12
The torque profile for each repetition performed during the resistance training was automatically
stored on the laptop computer for later analysis. Variables of interest in this demonstration project
were peak torque, average peak torque, and total work. Peak torque was taken as the highest torque
output from a single repetition measured in each individual set averaged across the three sets.
Average peak torque was the average of the peak torque from every individual repetition from all
three sets. Total work was the summation of work performed in all three sets. The data from the
warm-up set and from the first week of training were not included in this analysis.
IV. LMLSTP Phase IIA Data and Results
This section contains data collected only from the prime subjects who participated in the chamber
run. All data are expressed as mean + standard error (SE), unless otherwise noted. Although the
sample size is small, the data were analyzed statistically to provide objective information regarding the
trends in the data. Pre- to post-maximal and submaximal aerobic exercise data were statistically
analyzed using dependent t-tests. Pre- to post-submaximal exercise data from the VO2pk exercise
test were analyzed using a repeated measures analysis of variance (ANOVA).
A. Aerobic Exercise Countermeasure
Over the course of the nine weeks of the chamber confinement, crew members were prescribed to
perform a total of 23 aerobic exercise countermeasure sessions. The range of compliance to this
prescription was from 91% to 100% with a mean of 98+4%. Two crew members completed all
requested exercise sessions. Reasons for other crew members not completing all exercise sessions
included work scheduling and failure of environmental control systems.
During the chamber test, each crew member's individual aerobic exercise prescription was pre-
programmed into the cycle ergometer. Heart rate was recorded in 15-second intervals during each
exercise session using a heart rate monitor. The data were downloaded on a weekly basis and added
to each individual's database. The mean HR response (+SE) across all exercise sessions for each
subject is displayed in Figure 6. Each subject attained the desired exercise intensity for this counter-
measure protocol.
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Figure 6. Prime crew members' individual mean (+_SE) heart rate response to aerobic
exercise countermeasure across chamber confinement.
B. Resistive Exercise Countermeasure
Crew members were prescribed to perform a total of 26 resistive exercise countermeasure sessions.
The range of compliance to completing all or part of the daily resistive exercise prescription was
from 81% to 100% with a mean of 91+10%. Two subjects completed all the exercises prescribed
each day, and one subject completed all the exercises on 21 out of the 26 resistance training days.
No specific reason was given as to why this subject did not exercise on these days. Another subject
completed the upper body exercises on 22 of the 26 resistance exercise days, but due to a recurring
back pain completed the squats and heel raises during only 58% of the exercise sessions. This
subject had a previous history of back injury.
Peak torque, average peak torque, and total work data were reduced at early (week 2), mid (week 5),
and late (week 8) chamber stay (Figure 7). Because of the varying amount of compliance within
subjects, data were not statistically analyzed. The graphics display the mean (+SE) of peak torque for
each exercise session for the subjects who completed the exercise at all three time periods.
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C. Pre- to Post-Chamber Maximal Aerobic Exercise Test Results
The primary crew members' (n=4) mean (+SE) VO2pk was 2.82+0.32 L/min (39.9+5.5 mL/kg/min)
before entering the chamber (Figure 8). This corresponded to a mean test time of 13.0+0.5 min and
a peak workload of 238+22 watts. After the chamber stay, crew members significantly (p<0.05)
increased their total test time (13.9+0.4 min) and the peak workload achieved (269+24 watts).
Although this resulted in a mean increase in VO2pk of 7%, the improvement in VO2pk was not
statistically significant when expressed as either absolute (P=0.06) or relative (P=0.11) oxygen con-
sumption. Peak oxygen consumption increased to some degree in all crew members, ranging from
1% to 20%. The crew member who was most fit before entering the chamber had the least increase in
aerobic fitness. Mean peak HR was not changed from before (190-&-_2bpm) to after the chamber stay
(190+3 bpm).
+7%
+13%
Pre Post
Pre Post
Figure 8. Changes in peak aerobic exercise responses after chamber confinement (n--4).
The mean submaximal HR and blood pressure responses during the maximal exercise test were
analyzed (Figure 9). The HR response to the first two submaximal exercise workloads was
unchanged from pre- to post-chamber. However, the HR response at the third submaximal exercise
stage was significantly less (P<0.02) after the exercise training in the chamber (159+3 vs 149+6
bpm). Time principally affected, pre- to post-chamber, systolic blood pressures (SBP), but pressures
were not significantly different pre- to post-chamber at any particular submaximal exercise stage.
The diastolic blood pressures (DBP) during the submaximal exercise stages were significantly lower
during the second (82+2 vs 67+2 mmHg) and third stages (78+2 vs 68+3 mmHg). There was also a
main effect of time on the RPE reported during the submaximal exercise stages, but, similar to SBP,
there was no specific submaximal exercise stage in which the RPE were significantly different from
pre- to post-chamber.
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Figure 9. Mean (+_SE) heart rate, rating of perceived exertion, and
blood pressure responses to submaximal exercise stages.
D. Pre- to In-Chamber Submaximal Aerobic Exercise Test Results
All four prime crew members completed five submaximal exercise tests, two prior to and one each on
day 15, day 30, and day 58 of the chamber stay. Testing days were chosen to be similar to those
anticipated for crew members aboard ISS. Submaximal exercise tests consisted of cycling on an
electronically braked ergometer at 25%, 50%, and 75% of pre-chamber VO2pk in 5-minute stages.
Subjects performed an active recovery for five minutes at 25% of VO2pk. The pedaling cadence was
maintained at 75 rpm. Tests conducted before the chamber stay were performed in the EXL. The
other tests were self-administered by the subjects in the chamber. Although the pre-chamber tests
included measurements of VO2 and RPE, only HR data were collected in 15-second intervals using a
HR monitor during the in-chamber tests. Heart rate data were averaged over the last two minutes of
each stage.
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Figure 10. Mean heart rate (+_SE) during submaximal aerobic exercise tests for prime
crew across chamber confinement.
An ANOVA revealed no difference in HR at each of the workloads during the duplicate pre-chamber
submaximal aerobic exercise tests. Therefore, the data from the two pre-chamber tests were averaged
as a baseline measurement. Previous experience with other data sets [5, 6, 11] has suggested that the
HR response to the higher workloads is most affected by changes in training status. Therefore, an
ANOVA was performed on the HR response to the third submaximal exercise stage, 75% VO2pk,
across the four test times. Although there was a trend (P=0.12) toward a decrease in HR across time,
there was no significant difference between the HR during the submaximal exercise test from pre-
chamber to day 58 (Figure 10).
E. Metabolic Calibrations
Data listed in this section (Table 3) are specific to the prime crew members. The pre-chamber data
are expressed as mean + standard deviation. These data were provided to CTSD as a means to assess
the functioning of the environmental control systems.
Table 3. Metabolic Calibration Data for Prime Subjects Only (n=4)
VO2
(L/min)
VO2
(mL/kg/min)
VCO2
(L/min)
Me
(g/min)
Supine Rest 0.22+0.03 3.13+0.35 0.19+0.03 0.15+0.02
Seated Rest 0.23+0.02 3.30+0.36 0.19+0.02 0.16+0.02
Exercise Countermeasure 1.65+0.34 23.38+2.97 1.68+0.36 1.14+0.24
Submaximal Test 1.43+0.33 19.90+3.02 1.45+0.32 0.88+0.22
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F. Post-Chamber Debrief
All crew members reported sporadic performance of leisure and recreational exercise sessions before
entering the chamber. Exercise in which they engaged before chamber entry included cycling,
jogging, in-line skating, team sports, and calisthenics. All crew members reported that the exercise
routines performed during the chamber stay was of greater intensity and frequency than that which
they normally perform.
Each crew member reported perceptions of increased exercise endurance, muscular strength, and
general fitness by the conclusion of the chamber stay. Some reported increased feelings of well-
being as well as improved attitude as a result of the exercise sessions. However, there were a few
reported occasions in which exercise was not looked upon favorably because of fatigue from work
schedules. There were some reported incidents of muscle pain, at the beginning of exercise training,
probably delayed onset muscle soreness, but each was resolved without lingering effects.
The length of the exercise routines was reported as an appropriate minimum. In general, the crew
members perceived the exercise intensity and duration to be adequate, but there were occasions when
additional or more intense exercise was desired. On some days due to scheduling conflicts or hard-
ware malfunctions, some subjects performed both aerobic and resistive exercise on the same day.
Although the subjects reported that these exercise routines were adequate for the length of this
demonstration project, they recommended increased variety of routines for longer stays. Subjects
also reported that the frequency of exercise, six days of exercise with one day of rest, as a rest period
was adequate.
Crew members enjoyed the pre-programming of both exercise devices. The exercise on the cycle
ergometer was viewed favorably, but more variety of the exercise protocols was desired. A previous
crew had strongly recommended the use of the treadmill during the chamber stay, but this crew felt
that the cycle ergometer was adequate for their length of stay.
Each crew member responded favorably to the use of the resistive exercise device, despite some
minor problems with the computer controller. The feedback provided by the resistive exercise device
computer controller was seen as motivating. However, crew members recommended additional
exercises during the chamber stay and more training on use of the equipment and proper exercise
techniques. Arm curls and tricep pushdowns were attempted by some crew members on the current
exercise device during their chamber stay. The tricep exercise was acceptable but the arm curl
exercise was not. A supplementary resistive exercise device was suggested. Having EXL personnel
observe the crew members performing normal resistive exercise during the chamber stay was
suggested as a means to receive feedback on form.
There were positive comments regarding the mini-periodization routine employed in the resistive
exercise prescription. Interestingly, the crew members reported that at the beginning of the study the
resistive exercise on which slow speed of movement was employed with a low number of repetitions
within a set was the most difficult, but that at the end of study the exercise routine with a high speed
of movement and more repetitions of the exercise within a set was hardest.
All subjects reported that their intention was to maintain an exercise routine after completion of the
study. They each suggested that they would like to include more regular aerobic and/or resistive
exercise into their weekly routines. Post-chamber exercise routines may include cycling, jogging,
resistance training, swimming, in-line skating, and calisthenics.
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Overall, the crew members enjoyed their experiences with the exercise demonstration project. Each
crew member perceived a decrease in the level of effort required to perform the exercise routines as
the chamber stay progressed. Their experiences appear to have had a positive impact on their plans
for post-chamber exercise routines.
V. Discussion
A. Peak Aerobic Exercise Test
The performance of this exercise test before and after the chamber stay appears to have been well
tolerated. The duration of the exercise test allowed for adequate warm-up by the subject before
reaching high exercise intensities. The length of the tests was slightly longer than that suggested by
Shepherd [14]. A more personalized prescription of the maximal exercise protocol might resolve
this, but would require at least one additional test as a baseline prior to the exercise test which would
be accepted as the pre-chamber test.
All four crew members demonstrated an increase in peak workload achieved and total test time
completed, and improvements in submaximal exercise responses during the maximal exercise test.
However, the increase in VO2pk was not statistically significant.
B. Submaximal Exercise Test
One crew member showed a "classical" training response of decreasing HR at each submaximal
exercise test over test times (Figure 11). Two subjects showed a decline in HR on days 15 and 30, but
the HR response on day 58 was unchanged from the pre-chamber test. One subject showed essen-
tially no change in HR across testing times. There was no apparent difference between the subjects in
relation to their exercise prescription adherence which would explain the differences in the individual
responses. All four subjects trained at the same relative exercise intensity during the aerobic exercise
countermeasure.
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Figure 11. "Classical" effect of aerobic exercise training on heart rate response to
submaximal aerobic exercise as seen in one subject.
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It is interesting to note that lower submaximal HR responses were seen during the maximal exercise
test after the chamber test than before it. It is possible that the active work schedules and disrupted
sleep patterns of the subjects influenced the HR responses during the submaximal exercise tests in the
chamber. The more controlled atmosphere of the laboratory for the VO2pk exercise test after the
chamber run had been completed may have provided for better data acquisition to assess responses to
submaximal exercise intensities.
C. Muscular Strength Testing
There was no isokinetic muscular strength testing performed before or after the chamber stay. The
only data available to assess changes in muscular strength are those data collected as part of the crew
members normal exercise routines. These data are discussed in an earlier section (Chapter IV,
Section B, "LMLSTP Phase IIA Data and Results: Resistive Exercise Countermeasure").
D. Aerobic Exercise Countermeasure
Crew members from previous chamber tests participated in regular exercise, but this was the first time
exercise was prescribed for each crew member on an individual basis with respect to the aerobic
exercise protocol anticipated for use on ISS. Further, although previous crews believed that they
increased their fitness through the exercise training [13], this was the first time during LMLSTP that
improvements in fitness were objectively quantified.
Crew members increased their VO2pk by an average of 7% with a range of 1% to 20%. The subject
that experienced the least improvement in aerobic capacity as a result of the training performed
within the chamber had the highest aerobic capacity before the study. Conversely, the subject with
the lowest aerobic capacity had the greatest improvement. From this limited data set, it appears that
the performance of these exercise countermeasure protocols most benefits less fit subjects. Less fit
subjects are generally expected to benefit more than more fit subjects from the initiation of a
structured exercise regimen. Although the performance of a more intense protocol, one of longer
duration, may be indicated to improve the aerobic capacity of more fit ambulatory subjects, this
protocol has been shown to adequately maintain the aerobic capacity of bed-rested subjects [2, 3, 5],
and therefore may be satisfactory for spaceflight.
E. Resistive Exercise Countermeasure
Data from the resistive exercise countermeasure are difficult to interpret in two of the four subjects.
However, it appears that muscular strength was increased in all subjects who performed the exercise
requested. Improved subject motivation, increased variety in exercises performed, and more objective
testing protocols may improve results from future demonstration projects.
F. Recommendations for Future Studies
To improve the exercise countermeasure demonstration project and the quality of data collected, we
recommend implementing the following items for future chamber studies:
Modify exercise countermeasures to more accurately reflect current concepts for ISS. For
example, include treadmill exercise as well as more resistive exercises.
Use exercise hardware which is more flight-like.
Add VO2 and RPE measurements to in-chamber submaximal exercise tests. Also, note ambient
temperature and humidity when testing is conducted. This information may assist in the inter-
pretation of in-chamber data.
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• Add pre-andpost-chambermuscularstrengthandenduranceassessmentsto moreobjectively
quantifychangesin muscularfitnessasaresultof theresistiveexercisecountermeasure.
• Completemorepre-chamberresistiveexercisetrainingwithsubjectsto increasefamiliaritywith
thehardware.
• Add morevarietyin theaerobicandresistiveexerciseroutines.
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APPENDIX A
Subject Characteristics
Group Age (yrs) Height (cm) Weight (kg)
Prime 26 175 69.1
Prime 31 182 73.4
Prime 33 172 56.4
Prime 34 170 82.7
Backup 31 172 61.4
Backup 35 170 56.6
Backup 37 180 76.8
Backup 26 170 56.1
Mean Prime
SD Prime
Mean Backup
SD Backup
Mean All
SD All
31 175 70.4
4 5 10.9
32 173 62.7
5 5 9.7
32 174 66.6
4 5 10.4
Sex
M
M
F
M
M
M
M
F
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APPENDIX B
Pre-Chamber Peak Aerobic Exercise Test Data - All Subjects
Workloads (Watts)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 50 50 50 50 50 50 50 50 50 0
Workload 2 100 100 75 100 100 100 100 75 94 12
Workload 3 150 150 100 150 150 150 150 100 138 23
Max Workload 275 250 175 250 225 175 275 175 225 44
Test Time (min) 14 13 11.75 13.2 12.2 11 14 11.75 12.6 1.1
Oxygen Consumption (L/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 1.07 1.13 0.88 1.08 0.89 1.01 1.26 1.08 1.05 0.12
Workload 2 1.55 1.66 1.12 1.55 1.41 1.42 1.67 1.21 1.45 0.20
Workload 3 2.13 2.08 1.48 2.13 2.01 2.02 2.25 1.50 1.95 0.29
Max Workload 3.19 3.04 1.87 3.18 2.54 2.39 3.28 1.89 2.67 0.58
Oxygen Consumption (mL/kg/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 15.5 15.5 15.6 13.1 14.4 18.1 17.2 19.2 16.1 2.0
Workload 2 22.5 22.7 20.0 18.7 22.9 25.5 22.9 21.4 22.1 2.1
Workload 3 30.9 28.5 26.2 25.8 32.5 36.2 30.8 26.6 29.7 3.6
Max Workload 46.3 41.6 33.2 38.5 41.2 42.9 44.9 33.6 40.3 4.9
Heart Rate (bpm)
Subject 1 2 3 4 5 6 7 8 Mean
Workload l 109 105 104 101 119 100 100 124 108
Workload2 138 127 130 123 147 131 120 141 132
Workload3 160 160 160 154 163 162 141 167 158
Max Workload 185 196 190 188 188 175 185 184 186
Rating of Perceived Exertion
SD
9
9
8
6
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 1.5 1.5 2.5 1 2.5 1 2 2 1.8 0.6
Workload 2 3 3 3.5 3 3 2 2.5 2.5 2.8 0.5
Workload 3 3.5 4.5 4 4 5 3 4.5 5 4.2 0.7
Max Workload 9 9 9 10 9 4 9 9.5 8.6 1.9
5
130
165
180
6
140
162
180
7
148
163
190
8
144
166
174
Mean
143
161
177
Systolic Blood Pressure (mmHg)
Su_ect 1 2 3 4
Workload l 143 162 136 144
Workload2 151 168 146 164
Workload3 161 186 168 180
SD
9
8
9
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APPENDIX B
Pre-Chamber Peak Aerobic Exercise Test Data - All Subjects
Diastolic Blood Pressure (mmHg)
Subject 1 2 3 4 5 6 7 8 Mean
Workload 1 74 82 86 70 80 70 68 74 76
Workload 2 79 84 88 78 80 66 71 64 76
Workload 3 75 82 80 74 84 68 76 64 75
SD
6
8
7
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APPENDIX C
Pre- and Post-Chamber Peak Aerobic Exercise Test Data - Prime Subjects Only
Workloads (Watts)
Subject
Workload 1
Workload 2
Workload 3
Max Workload
Test Time (min)
Subject
Workload 1
Workload 2
Workload 3
Max Workload
Test Time (min)
Pre
1 2 3 4
50 50 50 50
100 100 75 100
150 150 100 150
275 250 175 250
14.0 13.0 11.8 13.2
Pre
Mean SE
50 0
94 6
138 13
238 22
13.0 0.5
Post
Mean SE
50 0
94 6
138 13
269 24
13.9 0.4
Post
1 2 3 4
50 50 50 50
100 100 75 100
150 150 100 150
300 275 200 300
14.5 14.0 12.7 14.5
A
0
0
0
31
0.9
%A
0%
0%
0%
13%
7%
Oxygen Consumption (L/min)
Subject
Workload 1
Workload 2
Workload 3
Max Workload
Subject
Workload 1
Workload 2
Workload 3
Max Workload
Pie Post
1 2 3 4 1 2 3 4
1.07 1.13 0.88 1.08 1.08 1.13 0.80 1.10
1.55 1.66 1.12 1.55 1.58 1.62 1.24 1.56
2.13 2.08 1.48 2.13 2.17 2.18 1.52 2.09
3.19 3.04 1.87 3.18 3.26 3.17 2.24 3.39
Pie
Mean SE
1.04 0.05
1.47 0.12
1.96 0.16
2.82 0.32
Post
Mean SE
1.03 0.08
1.50 0.09
1.99 0.16
3.02 0.26
Oxygen Consumption (ml/kg/min)
Pie
Subject 1 2
Workload 1 15.5 15.5
Workload 2 22.5 22.7
Workload 3 30.9 28.5
Max Workload 46.3 41.6
Pre
Subject Mean SE
Workload 1 14.9 0.6
Workload 2 21.0 1.0
Workload 3 27.9 1.2
Max Workload 39.9 2.7
A %A
-0.01 -1%
0.03 2%
0.03 2%
0.20 7%
Post
3 4 1 2 3 4
15.6 13.1 15.8 15.5 15.7 13.1
20.0 18.7 23.1 22.1 21.9 18.6
26.2 25.8 31.6 29.6 27.1 24.9
33.2 38.5 47.6 43.1 39.8 40.4
Post
Mean SE
15.0 0.6
21.4 1.0
28.3 1.5
42.7 1.8
A %A
0.1 1%
0.4 2%
0.5 2%
2.8 7%
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Pre- and Post-Chamber Peak Aerobic Exercise Test Data - Prime Subjects Only
Heart Rate (bpm)
Subject
Workload 1
Workload 2
Workload 3
Max Workload
Subject
Workload 1
Workload 2
Workload 3
Max Workload
Pre Post
1 2 3 4 1 2 3 4
109 105 104 101 104 113 107 96
138 127 130 123 126 131 124 117
160 160 160 154 150 162 151 134
185 196 190 188 186 196 184 193
Pre
Mean SE
105 2
130 3
159 2
190 2
Rating of Perceived Exertion
Post
Mean SE
105 4
125 3
149 6
190 3
ere
Subject 1 2 3
Workload 1 1.5 1.5 2.5
Workload 2 3 3 3.5
Workload 3 3.5 4.5 4
Max Workload 9 9 9
Pre
Subject Mean SE
Workload 1 1.6 0.3
Workload 2 3.1 0.1
Workload 3 4.0 0.2
Max Workload 9.3 0.3
Systolic Blood Pressure (mmHg)
Pre
A %A
0 0%
-5 -4%
-9 -6%
0 0%
Post
Mean
1.4
2.4
3.5
9.5
Post
4 1 2 3 4
1 1 1 2 1.5
3 2.5 2 2.5 2.5
4 3.5 3 4 3.5
10 9.5 9 10 9.5
SE A
0.2 -0.3
0.1 -0.8
0.2 -0.5
0.2 0.3
%A
-15%
-24%
-13%
3%
Post
Subject
Workload 1
Workload 2
Workload 3
Subject
Workload 1
Workload 2
Workload 3
1 2 3 4 1 2 3 4
143 162 136 144 119 161 123 129
151 168 146 164 140 173 130 146
161 186 168 180 149 195 144 160
Pre
Mean SE
146 6
157 5
174 6
Post
Mean
133
147
162
SE
10
9
11
A
-13
-10
-12
%A
-9%
-6%
-7%
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APPENDIX C
Pre- and Post-Chamber Peak Aerobic Exercise Test Data - Prime Subjects Only
Diastolic Blood Pressure (mmHg)
ere
Subject 1 2 3 4 1
Workload 1 74 82 86 70 60
Workload 2 79 84 88 78 62
Workload 3 75 82 80 74 60
Subject Mean SE Mean SD SE
Workload 1 78 4 67 7 3
Workload 2 82 2 67 4 2
Workload 3 78 2 68 6 3
Post
2 3 4
75 70 63
70 65 70
72 66 72
A %A
-11 -14%
-16 -19%
-10 -13%
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APPENDIX D
Pre-Chamber Submaximal Aerobic Exercise Test Data - All Subjects
Workloads (Watts)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 33 28 10 35 27 21 28 3 23 11
Workload 2 110 99 59 105 89 78 105 53 87 22
Workload 3 186 169 109 175 152 135 181 103 151 32
Oxygen Consumption (L/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 0.89 0.83 0.50 0.95 0.74 0.74 0.87 0.55 0.76 0.16
Workload 2 1.68 1.57 0.94 1.62 1.38 1.32 1.68 1.02 1.40 0.29
Workload 3 2.71 2.43 1.64 2.65 2.22 2.20 2.64 1.53 2.25 0.46
Oxygen Consumption (mL/kg/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workoad 1 12.8 11.2 8.8 11.3 11.9 13.1 11.4 9.8 11.3 1.4
Workload 2 24.0 21.4 16.4 19.2 22.4 23.3 22.1 18.0 20.8 2.7
Workload 3 38.8 33.1 28.7 31.5 36.0 38.8 34.7 27.1 33.6 4.4
Heart Rate (bpm)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 105 98 91 99 85 92 93 97 95 6
Workload 2 138 126 112 125 118 123 121 132 124 8
Workload 3 165 173 163 161 154 162 154 176 164 8
Rating of Perceived Exertion
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 1 1 2 1 1 0.5 1 1 1.1 0.4
Workload 2 2.5 2 3 3 3 2 3 2.5 2.8 0.4
Workload 3 5.5 5 4 5 5 3 6 5 4.6 0.9
Systolic Blood Pressure (mmHg)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload l 128 133 115 132 120 104 130 113 122 11
Workload2 152 165 119 151 163 148 148 144 149 14
Workload3 168 200 144 175 185 160 180 164 172 17
Diastolic Blood Pressure (mmHg)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 70 78 64 68 70 80 76 70 72 5
Workload 2 58 68 61 60 69 72 76 68 67 6
Workload 3 50 68 80 60 64 74 68 71 67 9
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APPENDIX E
Pre-Chamber Predicted Responses to Submaximal Aerobic Exercise Tests -
All Subjects
Predicted VO2 (L/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 0.80 0.76 0.47 0.80 0.64 0.60 0.82 0.47 0.67 0.15
Workload 2 1.60 1.52 0.94 1.59 1.27 1.20 1.64 0.95 1.34 0.29
Workload 3 2.39 2.28 1.40 2.39 1.91 1.79 2.46 1.42 2.01 0.44
Difference Between Actual and Predicted VO2 (L/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 0.09 0.06 0.03 0.15 0.10 0.14 0.05 0.08 0.09 0.04
Workload2 0.08 0.05 0.00 0.03 0.11 0.12 0.04 0.06 • 0.06 0.04
Workload 3 0.32 0.15 0.24 0.26 0.31 0.41 0.18 0.11 0.25 0.10
Heart Rate (bpm)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 99 89 82 89 105 88 89 93 92 7
Workload 2 130 125 117 123 133 117 120 124 124 6
Workload 3 162 162 152 156 162 147 151 154 156 6
Difference Between Actual and Predicted Heart Rate (bpm)
Subject 1 2 3 4 5 6 7 8 Mean SD
Workload 1 6 9 9 10 -20 4 4 4 3 10
Workload 2 8 1 -5 2 -15 6 1 8 1 8
Workload 3 3 11 11 5 -8 15 3 22 8 9
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APPENDIX F
Pre- and In-Chamber Submaximal Aerobic Exercise Test Data -
Prime Subjects Only
Subject 1
Workload 1
Workload 2
Workload 3
Subject 2
Workload 1
Workload 2
Workload 3
Pre 1
105
138
165
Pre 2 PreMean
109 107
146 142
173 169
Pre 2 PreMean
FD15 FD30 FD58
107 102 98
138 135 134
166 165 160
Pre 1
98
126
173
99 99
124 125
174 174
FD15 FD30
92 90
122 119
166 163
FD58
94
121
166
FD58
93
116
163
Subject 3
Pre 1 Pre 2 Pre Mean
Workload 1 91 96 94
Workload 2 112 121 117
Workload 3 163 163 163
FD15 FD30
90 94
115 114
160 153
Subject 4
Pre 1 Pre 2 PreMean
Workload l 99 97 98
Workload2 125 127 126
Workload3 161 164 163
FD15
97
128
158
FD30 FD58
109 109
133 133
162 162
. (,,•
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APPENDIX G
Pre-Chamber Aerobic Exercise Countermeasure Data - All Subjects
Workload (Watts)
Subject
40%-Warm-Up
60%
40%
70%
40%
80%
40%
90%
40%
80%
40%-Cool Down
VO2 (L/min)
Subject
40%-Warm-Up
60%
40%
70%
40%
80%
40%
90%
40%
80%
40%-Cool Down
1 2 3 4 5 6 7 8 Mean SD
79 70 39 77 64 55 74 33 61 17
141 127 79 133 114 101 135 73 113 26
79 70 39 77 64 55 74 33 61 17
171 155 99 161 139 123 166 93 138 30
79 70 39 77 64 55 74 33 61 17
202 183 119 189 164 146 197 113 164 35
79 70 39 77 64 55 74 33 61 17
232 212 139 217 189 169 227 133 190 39
79 70 39 77 64 55 74 33 61 17
202 183 119 189 164 146 197 113 164 35
79 70 39 77 64 55 74 33 61 17
1 2 3 4 5 6 7 8 Mean SD
1.38 1.32 0.89 1.38 1.19 1.09 1.48 0.73 1.18 0.26
2.02 1.82 1.18 1.72 1.63 1.47 2.10 1.16 1.64 0.35
1.54 1.36 0.98 1.58 1.34 1.24 1.63 0.86 1.31 0.28
2.30 2.02 1.32 2.10 1.91 1.74 2.35 1.23 1.87 0.42
1.62 1.46 0.99 1.63 1.42 1.34 1.75 0.94 1.39 0.30
2.59 2.27 1.58 2.39 2.22 1.98 2.71 1.51 2.16 0.44
1.67 1.68 1.10 1.79 1.45 1.40 1.69 1.00 1.47 0.29
2.88 2.54 1.67 2.72 2.48 2.17 2.94 1.74 2.39 0.49
1.83 1.70 1.23 1.92 1.56 1.50 1.86 1.10 1.59 0.30
2.80 2.50 1.62 2.56 2.47 2.14 2.74 1.62 2.30 0.47
1.59 1.47 0.89 1.53 1.31 1.43 1.63 0.90 1.34 0.29
VO2 (mL/kg/min)
Subject 1
40%-Warm-Up 19.9
60% 29.4
40% 22.4
70% 33.3
40% 23.5
80% 37.6
40% 24.3
90% 41.8
40% 26.5
80% 40.6
40%-Cool Down 23.1
2 3 4 5 6 7 8 Mean SD
17.9 15.8 16.8 19.4 19.2 19.3 13.1 17.7 2.3
24.7 20.9 20.9 26.6 25.9 27.4 20.7 24.5 3.4
18.4 17.4 19.1 21.8 21.9 21.3 15.2 19.7 2.6
27.6 23.5 25.4 31.2 30.7 30.7 21.9 28.0 4.1
20.0 17.5 19.7 23.2 23.6 22.9 16.6 20.9 2.8
31.0 28.1 29.0 36.2 35.0 35.4 26.8 32.4 4.2
22.9 19.6 21.7 23.7 24.7 22.0 17.8 22.0 2.4
34.6 29.7 33.0 40.6 38.3 38.3 31.0 35.9 4.5
23.2 21.8 23.3 25.5 26.4 24.3 19.6 23.8 2.4
34.0 28.8 31.0 40.3 37.8 35.8 28.9 34.6 4.8
20.1 15.9 18.5 21.3 25.2 21.2 16.0 20.2 3.3
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APPENDIX G
Pre-Chamber Aerobic Exercise Countermeasure Data - All Subjects
Heart Rate (bpm)
Su_ect 1 2 3 4 5 6 7 8 Mean SD
40%-Warm-Up 124 109 110 111 114 122 105 112 113 7
60% 146 132 125 127 134 142 125 138 133 8
40% 132 116 125 115 114 135 114 120 121 8
70% 155 156 157 148 148 158 133 159 152 9
40% 145 127 137 126 129 144 119 131 132 9
80% 169 171 166 158 162 171 172 167 5
40% 153 136 144 132 133 155 125 145 140 11
90% 175 185 178 169 173 180 158 179 174 8
40% 154 141 149 140 143 161 131 149 146 9
80% 174 183 175 166 170 181 157 178 173 9
40%-Cool Down 148 129 136 130 136 158 126 138 138 11
Rating of Perceived Exertion
Subject 1 2 3 4 5 6 7 8 Mean SD
40%-Warm-Up 1.5 1 2 1 3 1 2 1 1.6 0.7
60% 3 2.5 3 3 4 1 2 2 2.6 0.9
40% 2 2.5 2 2 3 1 2.5 1 2.0 0.7
70% 4 4 3 4 4.5 2 4 3 3.6 0.8
40% 3 3 2 2 3 2 3.5 1.5 2.5 0.7
80% 5 5 4 5 6 3 5 3.5 4.6 1.0
40% 3 3 3 2 3 3 3 2 2.8 0.5
90% 6.5 7.5 5 7 9 3.5 6 5 6.2 1.7
40% 3 3 3 2 3.5 3 4 2 2.9 0.7
80% 6.5 8 4 6 7.5 3 5.5 3.5 5.5 1.9
40%-Cool Down 3 3 2.5 2 3 2 4 2 2.7 0.7
Z
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Systolic Blood Pressure (mmHg)
Su_ect 1 2 3 4
40%-Warm-Up 118 128 140
60% 154 134 148
40% 124
70% 154 145 154
40% 140
80% 160 151 164
40% 145
90% 165 156 184
40% 143
80% 166 149 174
40%-Cool Down 158 133 132
5
140
162
164
204
202
29
6 7 8 Mean SD
139 140 132 134 8
153 159 132 149 12
148 158 143 17
149 177 140 155 12
143 163 149 13
158 178 144 159 12
140 169 151 16
170 185 140 172 21
136 169 149 17
148 189 150 168 21
125 166 143 18
APPENDIX G
Pre-Chamber Aerobic Exercise Countermeasure Data - All Subjects
Diastolic Blood Pressure (mmHg)
Subject 1 2 3 4 5 6 7 8 Mean SD
40%-Warm-Up 70 80 74 70 75 72 80 74 4
60% 64 76 70 80 78 80 60 73 8
40% 81 65 79 75 9
70% 58 84 70 70 78 80 64 72 9
40% 80 68 70 73 6
80% 64 81 72 60 68 58 67 8
40% 68 64 68 67 2
90% 60 84 70 80 64 82 68 73 9
40% 79 62 75 72 9
80% 56 82 70 64 74 64 66 68 8
40%-Cool Down 56 74 66 68 62 65 7
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APPENDIX H
Pre-Chamber Predicted Responses to Aerobic Exercise Countermeasure -
All Subjects
Predicted VO2 (L/min)
Subject 1 2 3 4 5 6 7 8 Mean SD
40%-Warm-Up 1.28 1.22 0.75 1.27 1.02 0.96 1.31 0.76 1.07 0.23
60% 1.91 1.82 1.12 1.91 1.52 1.43 1.97 1.13 1.60 0.35
40% 1.28 1.22 0.75 1.27 1.02 0.96 1.31 0.76 1.07 0.23
70% 2.23 2.13 1.31 2.23 1.78 1.67 2.30 1.32 1.87 0.41
40% 1.28 1.22 0.75 1.27 1.02 0.96 1.31 0.76 1.07 0.23
80% 2.55 2.43 1.50 2.54 2.03 1.91 2.62 1.51 2.14 0.47
40% 1.28 1.22 0.75 1.27 1.02 0.96 1.31 0.76 1.07 0.23
90% 2.87 2.74 1.68 2.86 2.29 2.15 2.95 1.70 2.41 0.53
40% 1.28 1.22 0.75 1.27 1.02 0.96 1.31 0.76 1.07 0.23
80% 2.55 2.43 1.50 2.54 2.03 1.91 2.62 1.51 2.14 0.47
40%-Cool Down 1.28 1.22 0.75 1.27 1.02 0.96 1.31 0.76 1.07 0.23
Difference Between
Subject
40%-Warm-Up
60%
40%
70%
40%
80%
40%
90%
40%
80%
40%-Cool Down
Actual and
1 2
0.10 0.10
0.11 0.00
0.26 0.14
0.06 -0.11
0.34 0.24
0.04 -0.16
0.39 0.46
0.00 -0.20
0.55 0.48
0.25 0.07
0.31 0.25
Predicted VO2 (L/min)
3 4 5 6 7 8 Mean SD
0.14 0.11 0.17 0.13 0.17 -0.03 0.11 0.06
0.06 -0.19 0.11 0.04 0.13 0.03 0.04 0.10
0.23 0.31 0.32 0.28 0.32 0.10 0.24 0.09
0.01 -0.13 0.13 0.07 0.05 -0.09 0.00 0.10
0.24 0.36 0.40 0.38 0.44 0.18 0.32 0.09
0.08 -0.15 0.19 0.07 0.09 -0.01 0.02 0.12
0.35 0.52 0.43 0.44 0.38 0.24 0.40 0.08
-0.01 -0.14 0.19 0.02 -0.02 0.04 -0.01 0.12
0.48 0.65 0.54 0.54 0.55 0.34 0.52 0.09
0.12 0.02 0.44 0.23 0.12 0.11 0.17 0.13
0.14 0.26 0.29 0.47 0.32 0.14 0.27 0.11
Predicted Heart Rate (bpm)
Subject
40%-Warm-Up
60%
40%
70%
40%
80%
40%
90%
40%
80%
40%-Cool Down
1 2
118 111
143 140
118 111
156 154
118 111
169 169
118 111
181 184
118 111
169 169
118 111
3 4 5 6 7 8 Mean SD
103 110 122 106 108 111 111 6
131 136 145 129 132 136 137 6
103 110 122 106 108 111 111 6
145 150 156 141 145 148 149 6
103 110 122 106 108 111 111 6
159 163 167 153 157 161 162 6
103 110 122 106 108 111 111 6
173 177 179 165 169 173 175 6
103 110 122 106 108 111 111 6
159 163 167 153 157 161 162 6
103 110 122 106 108 111 111 6
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APPENDIX H
Pre-Chamber Predicted Responses to Aerobic Exercise Countermeasure -
All Subjects
Difference Between Actual and Predicted Heart Rate (bpm)
Subject 1 2 3 4 5 6
40%-Warm-Up
60%
40%
70%
40%
80%
40%
90%
40%
80%
40%-Cool Down
7 8 Mean SD
6 -3 7 1 -9 16 -4 1 2 8
3 -9 -7 -10 -12 13 -7 2 -3 8
14 5 22 5 -8 29 6 9 10 11
-1 2 12 -3 -8 17 -12 11 2 10
27 16 34 16 7 38 11 20 21 11
0 2 7 -6 -6 18 11 4 9
35 25 41 22 11 49 17 34 29 13
-6 1 5 -8 -6 15 -12 6 -1 9
36 30 46 30 21 55 23 38 35 12
5 14 16 3 3 28 -1 17 11 10
30 18 33 20 14 52 18 27 26 12
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APPENDIX I
In-Chamber Aerobic Exercise Countermeasure Data - Prime Subjects Only
Subject 1
Session 40% 60% 40% 70% 40% 80% 40% 90% 40% 80% 40% Notes
1 118 134 124 149 127 159 134 170 142 167 139
2 120 134 127 148 134 158 142 170 150 169 130
3 131 154 137 162 140 170 144 173 156 173 144
4 125 146 129 153 130 162 137 168 144 166 135
5 127 143 131 155 135 163 139 169 146 167 137
6 125 141 128 154 128 160 135 166 140 166 135
7 Submax
8 137 149 143 154 148 166 151 169 153 168 136
9 130 151 134 156 139 165 142 172 147 170 145
10 126 141 131 152 138 162 139 167 143 165 134
11 HWProblems
12 123 143 126 152 133 162 138 167 142 165 131
13 117 137 123 151 124 157 130 161 139 163 137
14 Submax
15 140 125 150 127 159 136 167 144 165 139
16 121 149 127 155 142 162 140 169 145 165 137
17 120 143 132 155 134 162 140 169 145 166 143
18 139 152 139 160 148 167 148 173 152 169 145
19 HWProblems
20 117 136 121 149 130 155 134 163 136 164 130
21 117 137 124 150 127 158 138 165 144 161 133
22 114 134 118 145 129 156 133 164 139 163 139
23 Submax
Mean 124 142 129 153 134 161 139 168 145 166 137
SD 7 7 6 4 7 4 5 3 5 3 5
ii¸ :!_i_
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Session
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
22
23
24
25
Mean
SD
APPENDIX I
In-Chamber Aerobic Exercise Countermeasure Data - Prime Subjects Only
Subject 2
40% 60% 40% 70% 40% 80% 40% 90% 40% 80% 40% No_s
108 135 114 151 115 165 126 180 139 176 125
112 141 119 160 117 169 130 182 143 179 131
119 140 119 162 133 171 138 184 150 181 135
115 140 117 159 126 175 136 182 148 183 129
113 141 119 155 130 170 133 183 142 181 127
107 135 121 151 125 168 129 181 136 177 126
Submax
103 134 113 160 135 165 132 181 148 178 137
109 132 117 145 120 163 137 180 135 176 121
111 137 119 151 122 168 128 176 138 174 118
105 136 111 152 120 160 122 174 134 171 128
109 135 106 146 126 159 121 175 128 174 126
119 138 121 154 118 167 131 179 136 175 123
Submax
132 113 145 117 161 121 172 140 170 119
108 136 117 145 122 162 129 172 131 174 130
111 138 124 153 123 163 130 174 133 170 119
119 139 118 149 126 162 129 171 135 171 124
Submax
111 137 117 152 123 165 129 178 138 175 126
5 3 4 6 6 4 5 4 6 4 6
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APPENDIX I
In-Chamber Aerobic Exercise Countermeasure Data - Prime Subjects Only
Session
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
Mean
SD
Subject 3
40% 60% 40% 70% 40% 80% 40% 90% 40% 80% 40% Notes
HWProblems
105 125 111 139 115 155 124 164 139 162 120
104 120 107 132 111 149 124 158 131 155 116
116 131 119 148 126 162 140 170 138 167 123
108 126 107 141 113 152 117 161 130 155 116
107 127 111 148 115 161 128 168 139 170 126
Submax
107 122 111 144 114 162 125 171 140 168 118
97 117 102 142 115 155 121 166 132 165 114
108 126 112 143 117 159 125 169 143 165 124
101 118 106 126 111 140 119 153 130 156 111
121 122 112 136 115 147 121 160 130 156 112
106 123 108 140 114 152 125 162 130 161 115
Submax
99 123 107 136 109 150 115 162 123 154 113
98 115 96 128 110 146 116 160 125 154 116
101 119 104 138 118 154 118 164 133 160 120
98 109 99 126 99 144 110 150 114 154 111
111 125 114 141 118 161 126 171 134 164 120
111 120 104 138 113 152 122 164 127 169 114
104 128 ill 139 108 152 120 162 127 161 120
106 125 108 134 115 149 118 162 123 165 116
101 121 107 135 114 156 122 163 127 168 143
Submax
105 122 107 137 113 153 122 163 131 161 118
6 5 5 6 5 6 6 5 7 6 7
iIi_ :_,
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In-Chamber Aerobic Exercise Countermeasure Data - Prime Subjects Only
Subject 4
Session 40% 60% 40% 70% 40% 80% 40% 90% 40% 80% 40%
1
2 119 136 121 145 124 156 131 165 138 164 130
3 113 129 115 137 124 149 128 164 134 159 129
4 109 128 114 139 121 151 127 162 137 163 128
5 113 132 115 136 121 152 127 165 136 164 125
6 104 124 111 137 117 151 124 164 137 162 125
7 /
8 113 128 115 137 121 152 126 163 134 161 124
9 117 142 125 148 128 161 134 167 144 167 133
10 120 138 122 148 127 154 135 167 141 163 133
11 117 136 123 143 125 153 134 165 140 163 134
12 110 130 120 140 128 153 130 164 142 164 133
13 116 127 113 141 120 151 134 163 139 162 125
14
15 105 127 113 137 121 152 131 164 140 162 128
16 113 132 121 143 123 153 130 160 137 159 126
17 113 133 120 148 124 156 138 164 142 164 130
18 117 135 121 143 125 156 132 165 140 160 127
19 120 136 120 141 120 153 129 161 137 160 124
20 118 133 119 144 124 152 127 161 134 158 127
21 116 134 116 145 122 153 127 160 132 157 132
22 116 135 123 147 125 156 131 162 139 161 130
23 122 141 125 148 129 158 136 164 142 164 136
24 115 134 118 142 120 148 123 160 132 157 125
25 116 130 119 143 117 151 125 159 130 156 119
26
Mean 114 132 118 142 123 153 130 163 137 161 128
SD 4 5 4 4 3 3 4 2 4 3 4
Noms
Did Submax
Submax
Submax
Submax
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APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
Subject 1 - Bench Press
HI (12 repetitions @ 50°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 5441 109.5 127.6
WEEK 3 5222 112.7 138.8
WEEK 4 5627 116.3 142.7
WEEK 5 5969 122.7 151.4
WEEK 6 5995 126.9 153.7
WEEK 7 6002 127.7 151.2
WEEK 8 5957 128.2 152.4
WEEK 9 7248 141.4 166.3
LO (6 repetitions @ 20°/s)
TOTAL TW (ft-lb)
WEEK 2 3910
WEEK 3 3056
WEEK 4 4331
WEEK 5 4427
WEEK 6 4223
WEEK 7 4204
WEEK 8 4227
WEEK 9 4442
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
184.6 213.3
187.9 205.0
196.5 220.8
199.0 216.4
201.2 228.8
207.5 233.0
210.4 234.4
216.1 235.6
IVIED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 4626
WEEK 3 4689
WEEK 4 4723
WEEK 5 4650
WEEK 6 4390
WEEK 7 zi459
WEEK 8 5495
WEEK 9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
150.4 170.0
149.9 171.5
156.3 180.1
157.4 178.9
155.2 178.7
164.8 187.5
168.5 191.1
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APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
HI (12 repetitions @ 50°Is)
Subject I - Seated Press
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 4495 82.8 92.8
WEEK 3 4563 87.3 99.2
WEEK 4 5272 86.0 100.6
WEEK 5 4813 88.0 99.7
WEEK 6 5109 89.3 128.7
WEEK 7 4520 91.1 101.0
WEEK 8 4753 96.7 110.4
WEEK 9 5361 101.8 116.3
LO (6 repetitions @ 20°Is)
TOTAL TW
WEEK 2
WEEK 3
WEEK 4
WEEK 5
WEEK 6
WEEK 7
WEEK 8
WEEK 9
(ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
4137 128.3 168.6
3512 126.5 158.5
3607 130.5 176.5
3776 140.9 151.3
3916 143.0 163.1
3460 132.2 172.9
4261 157.7 176.3
3430 142.0 154.4
(ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
108.7 139.7
110.1 144.9
107.9 119.7
MED (8 repetitions @ 35°/s)
TOTAL TW
WEEK 2 4764
WEEK 3 3892
WEEK 4 3646
WEEK 5 3693
WEEK 6 3804
WEEK 7 3879
WEEK 8 4494
WEEK 9
110.5 124.3
119.9 134.2
131.6 149.9
134.6 147.8
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APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
Subject 1 - Squat
HI (12 repetitions @ 50°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 14949 271.0 311.1
WEEK 3 17687 275.4 317.4
WEEK 4 18308 285.7 345.6
WEEK 5 18931 283.9 318.2
WEEK 6 19020 284.3 318.7
WEEK 7 18739 298.8 341.4
WEEK 8 19296 293.5 333.5
WEEK 9 19146 319.7 359.7
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 9616 346.4 420.6
WEEK 3 10977 363.2 403.3
WEEK 4 11764 366.5 413.4
WEEK 5 12013 399.6 437.4
WEEK 6 12284 390.3 446.0
WEEK 7 11794 406.3 461.4
WEEK 8 12950 421.1 476.0
WEEK 9 12645 419.8 472.0
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 13690 347.6 383.4
WEEK 3 14503 333.4 380.2
WEEK 4 12896 326.0 383.2
WEEK 5 14204 333.1 366.0
WEEK 6 13526 345.9 387.5
WEEK 7 14036 344.6 400.3
WEEK 8 14654 367.4 406.1
WEEK 9
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APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
Subject 1 - Heel Raises
HI (12 repetitions @ 50°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 3769 192.7 240.7
WEEK 3 2879 157.2 220.7
WEEK 4 3573 166.4 221.6
WEEK 5 3616 173.4 249.6
WEEK 6 3577 189.9 252.5
WEEK 7 3868 186.9 230.8
WEEK 8 3624 198.0 241.4
WEEK 9 4233 209.5 256.5
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 2334 282.1 303.7
WEEK 3 2460 257.3 317.1
WEEK 4 2161 280.4 307.8
WEEK 5 2600 286.7 340.9
WEEK 6 2634 292.3 333.7
WEEK 7 2734 271.6 334.4
WEEK 8 2669 304.1 346.9
WEEK 9 3108 309.9 339.9
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 2548 215.1 294.9
WEEK 3 2540 211.3 272.6
WEEK 4 2258 215.2 288.4
WEEK 5 2521 192.4 274.8
WEEK 6 2854 216.2 270.0
WEEK 7 3506 252.7 287.8
WEEK 8 3285 244.3 283.1
WEEK 9
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In-Chamber Resistive Exercise Countermeasure Data
HI (12 repetitions @ 50°Is)
Subject 1 - Lat Pull
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 6165 113.1 128.6
WEEK 3 6538 118.6 132.5
WEEK 4 7289 120.1 132.2
WEEK 5 6753 129.0 143.5
WEEK 6 6790 128.0 143.1
WEEK 7 6431 125.7 141.7
WEEK 8 6571 125.6 142.4
WEEK 9 7196 131.2 148.5
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb)
WEEK 2 4052
WEEK 3 3962
WEEK 4 3823
WEEK 5 4533
WEEK 6 4515
WEEK 7 4049
WEEK 8 4546
WEEK 9 4424
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
154.9 173.0
159.9 174.9
162.4 177.7
168.5 188.4
167.0 184.7
158.6 174.8
165.2 185.1
167.9 183.9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
137.4 155.2
144.6 159.1
147.6 163.2
152.9 164.7
150.2 166.1
152.2 166.8
153.8 168.4
:'_:ii!i_;
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MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 5109
WEEK 3 4927
WEEK 4 4913
WEEK 5 5295
WEEK 6 5434
WEEK 7 5353
WEEK 8 5744
WEEK 9
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In-Chamber Resistive Exercise Countermeasure Data
i
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Subject 2 - Bench Press
HI (12 repetitions @ 50°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 7590 145.1 164.5
WEEK 3 8682 160.8 179.1
WEEK 4 8767 150.9 174.6
WEEK 5 10038 167.5 189.9
WEEK 6 9043 169.8 191.8
WEEK 7 8699 164.1 185.8
WEEK 8 8810 164.8 185.9
WEEK 9 9139 171.4 195.8
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 5318 210.9 244.2
WEEK 3 5381 213.2 239.0
WEEK 4 5384 217.1 242.2
WEEK 5 5627 232.0 265.6
WEEK 6 2081 235.0 248.2
WEEK 7 6115 245.6 268.6
WEEK 8 5803 256.8 284.5
WEEK 9 5488 256.5 295.5
L
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MED (8 repetitions @ 35°/s)
TOTAL TW
WEEK 2 6751
WEEK 3 6294
WEEK 4 6069
WEEK 5 7069
WEEK 6 6533
WEEK 7 6590
WEEK 8 6614
WEEK 9
(ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
187.1 214.6
180.5 210.2
168.7 213.9
200.8 218.3
180.1 212.1
203.4 220.0
207.5 224.9
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In-Chamber Resistive Exercise Countermeasure Data
HI (12 repetitions @ 50°/s)
Subject 2 - Seated Press
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 6636 113.7 126.4
WEEK 3 6852 110.0 123.1
WEEK 4 7572 115.7 125.9
WEEK 5 7012 111.4 122.1
WEEK 6 7376 121.2 134.8
WEEK 7 7604 137.9 185.8
WEEK 8 7430 116.4 128.2
WEEK 9 8057 130.0 143.1
LO (6 repetitions @ 20°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 4054 140.0 151.0
WEEK 3 4924 156.5 193.7
WEEK 4 4477 146.9
WEEK 5 4360 147.8
156.9
156.3
WEEK 6 3034 151.8 163.5
WEEK 7 4611 155.9 166.4
WEEK 8 5196 163.6 180.5
WEEK 9 4195 159.1 184.9
• } ,
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MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2
WEEK 3
5325
5601
WEEK 4 5189
WEEK 5 5710
WEEK 6 4921
WEEK 7 4825
WEEK8 5870
WEEK 9
AVERAGE PT (fi-lb) PEAK PT (fi-lb)
137.4 150.3
128.2 183.4
126.5 134.7
138.4 150.2
131.7 138.9
134.8 147.4
144.6 156.4
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In-Chamber Resistive Exercise Countermeasure Data
Subject 2 - Squats
HI (12 repetitions @ 50°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 16441 224.8 306.9
WEEK 3 19119 287.5 331.6
WEEK 4 19653 295.2 364.4
WEEK 5 19928 327.3 375.5
WEEK 6 20921 314.5 362.3
WEEK 7 18722 309.7 351.8
WEEK 8 21141 332.0 374.6
WEEK 9 24231 347.8 397
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 7115 219.2 275.1
WEEK 3 9451 253.7 284.8
WEEK 4 10982 285.1 326.1
WEEK 5 9894 311.9 343.2
WEEK 6 10964 326.0 359.1
WEEK 7 12304 328.8 376.3
WEEK 8 12504 340.3 384.9
WEEK 9 10264 323.1 382.4
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 13163 249.0 288.2
WEEK 3 13579 251.9 276.7
WEEK 4 11546 262.6 307.2
WEEK 5 15416 325.4 405.8
WEEK 6 14746 321.7 370.4
WEEK 7 15037 327.4 389.8
WEEK 8 17537 365.6 408.1
WEEK 9
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In-Chamber Resistive Exercise Countermeasure Data
repetitions @ 50°/s)
Subject 2 - Heel Raises
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 3769 179.1 236.2
WEEK 3 4722 228.7 280
WEEK 4 5770 263.9 307.2
WEEK 5 5253 296.8 354.8
WEEK 6 8723 326.4 376.1
WEEK 7 6479 105.0 123.6
WEEK 8 5355 321.9 353.5
WEEK 9 6966 345.5 390.8
(, _,:
LO (6 repetitions @ 20°Is)
TOTAL TW
WEEK 2 2119
WEEK 3 2500
WEEK 4 2632
WEEK 5 2948
WEEK 6 3454
WEEK7 3111
WEEK 8 2247
WEEK 9 3444
(ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
226.8 274.8
294.4 337
323.6 379.7
310.2 343.3
329.9 355.7
357.6 405.4
332.9 393.2
372.6 439
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 2616
WEEK 3 3508
WEEK 4 3225
WEEK 5 4156
WEEK 6 3966
WEEK 7 3456
WEEK 8 5729
WEEK 9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
248.3 296.7
278.6 326.9
287.2 340.8
326.7 378.7
325.0 366.8
317.9 360.9
367,4 420.1
( • :? • i¸.
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APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
Subject 2 - Lat Pull
HI (12 repetitions @ 50°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 7949 137.9 154.3
WEEK 3 8592 141.9 160.2
WEEK 4 9680 150.1 166.9
WEEK 5 9568 153.7 165.0
WEEK 6 8699 164.1 185.8
WEEK 7 8934 142.1 156.9
WEEK 8 9950 148.3 168.1
WEEK 9 10940 161.6 176.9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 4965 175.3 210.1
WEEK 3 5516 185.8 202.7
WEEK 4 5558 193.4 213.1
WEEK 5 5605 190.0 203.6
WEEK 6 6115 245.6 268.6
WEEK 7 6295 211.1 232.1
WEEK 8 6357 198.9 220.7
WEEK 9 5904 197.9 219.1
MED (8 repetitions @ 35°/s)
TOTAL TW (fi-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 6691 173.9 199.7
WEEK 3 6844 171.0 183.5
WEEK 4 6485 162.0 178.4
WEEK 5 7757 187.0 198.5
WEEK 6 6919 176.7 194.6
WEEK 7 6594 172.8 185.2
WEEK 8 7882 180.5 203.4
WEEK 9
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In-Chamber Resistive Exercise Countermeasure Data
i Subject 3 - Bench Press
HI (12 repetitions @ 50°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2
WEEK 3 2425 52.8 63.3
WEEK 4 2485 57.5 70.9
WEEK 5 2210 54.4 73.2
WEEK 6 3150 60.6 76.9
WEEK 7 2821 61.2 72.4
WEEK 8
WEEK 9
LO (6 repetitions @ 20°/s)
TOTAL TW (ft-lb)
WEEK 2 1900
WEEK 3 1702
WEEK4 1910
WEEK 5 1920
WEEK 6 1896
WEEK 7 2064
WEEK 8 2174
WEEK 9 1968
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
79.5 100.6
88.1 101.4
102.9 115.2
93.3 106.8
89.0 104.7
82.4 94
96.5 126.1
94.5 111.9
i ' 'r
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 1831
WEEK 3
WEEK 4
WEEK 5 2410
WEEK 6
WEEK 7 2285
WEEK 8 2500
WEEK 9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
61.6 76.9
81.5 91.2
83.4 100.4
83.3 110.6
47
APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
HI (12 repetitions @ 50°/s)
Subject 3 - Seated Press
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2
WEEK 3 2357 46.7 56.4
WEEK 4 2485 50.7 63.7
WEEK 5 2473 49.8 62.9
WEEK 6 2625 51.2 60.8
WEEK 7 2300 50.2 63.5
WEEK 8
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 1799 69.3 83.4
WEEK 3 1837 70.5 90.9
WEEK 4 2022 76.2 90.1
WEEK 5 1875 71.2 80.7
WEEK 6 2092 73.3 88.8
WEEK 7 2092 76.5 91.4
WEEK 8 2083 81.3 98.4
WEEK 9 2023 81.0 94.7
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
65.2 73.4
63.8 74.2
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 2388
WEEK 3
WEEK 4
WEEK 5 2536
WEEK 6
WEEK 7 2334
WEEK 8 2552
WEEK 9
64.2 74.0
70.9 81.2
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In-Chamber Resistive Exercise Countermeasure Data
repetitions @ 50°/s)
Subject 3 - Squats
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2
WEEK 3 3598 69.9 95.1
WEEK 4 4395 78.2 100.7
WEEK 5 5806 96.9 119.7
WEEK 6 5491 100.6 149.9
WEEK 7 6747 115.2 136.1
WEEK 8
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb)
WEEK 2
AVERAGE PT (ft-lb)
3076 126.0
WEEK 3 2641 113.3
WEEK 4 3946 134.2
WEEK 5 3351 111.5
WEEK 6 4235 133.9
WEEK 7 4251 136.7
WEEK 8 4690 171.3
WEEK 9 5848 208.6
PEAK PT (ft-lb)
157.6
150.4
152.8
137.9
162.6
162.0
192.0
252.5
PEAK PT (ft-lb)
114.3
145
202.3
187.6
i
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 2783
WEEK 3
WEEK 4
WEEK 5 4358
WEEK 6
WEEK 7 6218
WEEK 8 6323
WEEK 9
AVERAGE PT (ft-lb)
83.8
111.1
161.6
158.9
• .i_ ,
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Subject 3 - Heel Raises
HI (12 repetitions @ 50°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2
WEEK 3 1091 81.0 106.8
WEEK 4 1499 93.0 117.4
WEEK 5 1287 84.9 103.8
WEEK 6 1367 106.4 138.6
WEEK 7 1749 104.8 133.3
WEEK 8
WEEK 9
LO (6 repetitions @ 20°/s)
TOTAL TW (ft-lb)
WEEK 2 626
WEEK 3 841
WEEK 4 826
WEEK 5 648
WEEK 6 926
WEEK 7 1063
WEEK 8 1544
WEEK 9 1414
AVERAGE PT (ft-lb)
108.3 140.4
103.7 138.0
128.7 158.3
99.2 112.8
131.7 151.4
146.9 179.3
196.6 261.2
223.7 256.9
PEAK PT (ff-lb)
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 954
WEEK 3
WEEK 4
WEEK 5 830
WEEK 6
WEEK 7 1366
WEEK 8 1699
WEEK 9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
101.6 133.3
95.3 133.4
151.4 190.6
146.1 179.5
5O
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In-Chamber Resistive Exercise Countermeasure Data
HI (12 repetitions @ 50°/s)
Subject 3 - Lat Pulls
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (fl-lb)
WEEK 2
WEEK 3 2294 43.2 54.8
WEEK 4 2679 54.2 62.6
WEEK 5 2897 58.7 72.8
WEEK 6 2960 60.4 68.8
WEEK 7 2638 57.0 70.1
WEEK 8
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 2104 84.9 103.7
WEEK 3 1978 81.9 91.1
WEEK 4 2129 88.3 95.4
WEEK 5 1903 78.2 89.1
WEEK 6 2247 86.6 95.9
WEEK 7 2030 85.8 93.0
WEEK 8 2424 97.3 111.3
WEEK 9 2356 99.0 107.2
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 2392 68.1 80.1
WEEK 3
WEEK 4
WEEK 5 2753 75.4 82.6
WEEK 6
WEEK 7 2489 76.0 84.3
WEEK 8 3012 83.8 97.5
WEEK 9
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In-Chamber Resistive Exercise Countermeasure Data
Subject 4 - Bench Press
HI (12
WEEK 2
WEEK 3
WEEK 4
repetitions@ 50°/s)
TOTAL TW(ff-lb)
4431
5199
4777
5302
AVERAGE PT (ff-lb) PEAK PT (fi-lb)
84.9 104.3
91.6 109
97.7 110.6
WEEK 5 102.7 117.9
WEEK 6 4212 99.4 114.9
WEEK 7 4485 103.0 135.2
WEEK 8 5483 115.8 131.9
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ff-lb) AVERAGE PT (ff-lb) PEAK PT (ft-lb)
WEEK2 3666 138.4 168.1
WEEK3 2990 130.6 141.7
WEEK4 3765 149.7 168.6
WEEK5 3317 142.2 156.5
WEEK6 3669 159.4 175.5
WEEK7 3685 152.9 166.0
WEEK 8
WEEK 9
MED (8 repetitions @ 35°/s)
TOTAL TW (ff-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK2 3799 111.6 136.9
WEEK3 3587 103.8 119.0
WEEK4 3807 130.0 150.8
WEEK5 3983 133.4 152.9
WEEK6 3610 136.3 154.2
WEEK 7
WEEK8 3787 135.9 156.1
WEEK 9
52
i:!:i_I¸
i ¸ _ :
APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
Subject 4 - Seated Press
HI (12 repetitions @ 50°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 3504 60.8 71.8
WEEK 3 4328 68.4 79.9
WEEK 4 4032 76.6 91.9
WEEK 5 3922 72.0 87.9
WEEK 6 4116 71.9 83.9
WEEK 7 4029 84.2 96.2
WEEK 8 3603 93.9 107.6
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 2796 100.1 111.4
WEEK 3 2936 102.2 109.3
WEEK 4 3053 107.8 114.0
WEEK 5 2714 110.0 120.1
WEEK 6 3070 111.6 117.4
WEEK 7 2468 120.1 128.9
WEEK 8
WEEK 9
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 3361 84.0 96.3
WEEK 3 3068 82.5 93.4
WEEK 4 2998 90.7 101.4
WEEK 5 3412 92.7 103.1 _
WEEK 6 3664 103.1 113.5
WEEK 7
WEEK 8 3543 108.0 118.7
WEEK 9
i,i _ i
53
HI (12
APPENDIX J
In-Chamber Resistive Exercise Countermeasure Data
repetitions @ 50°Is)
Subject 4 - Squats
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 9568 185.8 230.4
WEEK 3 10048 202.0 239.7
WEEK 4 11103 238.4 288.9
WEEK 5 13688 247.5 311.5
WEEK 6
WEEK 7
WEEK 8
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 9115 316.7 360.4
WEEK 3 8923 348.9 416.9
WEEK 4 10184 398.2 474.0
WEEK 5 9188 388.6 433.6
WEEK 6 5966 250.9 317.2
WEEK 7
WEEK 8
WEEK 9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
278.0 319.3
270.1 328.2
307.4 350.3
316.0 358.2
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 10171
WEEK 3 8641
WEEK 4 9505
WEEK 5 8537
WEEK 6
WEEK 7
WEEK 8
WEEK 9
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In-Chamber Resistive Exercise Countermeasure Data
Subject 4 - Heel Raises
HI (12 repetitions @ 50°Is)
TOTAL TW (fl-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 5067 272.9 351.9
WEEK 3 3942 296.0 336.6
WEEK 4 6351 343.9 391.8
WEEK 5 6303 263.2 315.5
WEEK 6
WEEK 7
WEEK 8
WEEK 9
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK 2 3167 365.8 419.8
WEEK 3 3015 398.1 436.8
WEEK 4 2466 374.7 438.6
WEEK 5 2366 356.1 419.3
WEEK 6 1783 269.3 308.6
WEEK 7
WEEK 8
WEEK 9
MED (8 repetitions @ 35°/s)
TOTAL TW (ft-lb)
WEEK 2 3893
WEEK 3 2890
WEEK 4 2594
WEEK 5 2553
WEEK 6
WEEK 7
WEEK 8
WEEK 9
AVERAGE PT (ft-lb) PEAK PT (ft-lb)
319.0 386.8
351.4 422.7
359.9 421
350.2 438.1
i i_
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In-Chamber Resistive Exercise Countermeasure Data
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Subject 4 - Lat Pulls
HI (12 repetitions @ 50°Is)
TOTAL TW
WEEK 2 4528
WEEK 3 6114
WEEK 4 5613
WEEK 5 5699
WEEK 6 6490
WEEK 7 6823
WEEK 8 5424
WEEK 9
(ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
85.1 101.5
99.5 120.9
107.7 133.5
107.9 124.5
112.5 1998
133.9 148.6
141.7 152.8
i ;i
i ::_i¸ ,
LO (6 repetitions @ 20°Is)
TOTAL TW (ft-lb) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK2 3834 141.4 155.8
WEEK3 4220 153.6 166.0
WEEK 4 4441 167.0 178.6
167.6 180.1
171.8 179.2
WEEK 5 3996
WEEK 6 4460
WEEK 7 3937 180.7 191.9
WEEK 8
WEEK 9
MED(8 repetitions@35°/s)
TOTAL TW (if-b) AVERAGE PT (ft-lb) PEAK PT (ft-lb)
WEEK2 4635 123.3 138.7
WEEK3 4303 125.4 138.1
WEEK4 4658 135.9 150.5
WEEK5 5041 143.8 157.5
WEEK 6 5456 151.8 164.3
WEEK 7
WEEK 8 5435 163.4 173.8
WEEK 9
;iI
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APPENDIX K
Pre-Chamber Metabolic Calibration Data - All Subjects
ii _ ,
Supine Rest
Subject 1 2 3 4 5 6 7 8 Mean SD
VO2 (mL/kg/min) 3.42 3.30 3.17 2.62 3.82 3.49 3.43 3.43 3.34 0.34
VO2 (L/min) 0.24 0.24 0.18 0.22 0.24 0.20 0.26 0,19 0.22 0.03
VCO2 (L/min) 0.19 0.22 0.15 0.18 0.21 0.16 0.22 0.15 0.19 0.03
Me (g/min) 0.17 0.17 0.12 0,15 0.16 0.12 0.16 0.13 0.15 0.02
Seated Rest
Subject 1 2 3 4 5 6 7 8 Mean SD
VO2 (mL/kg/min) 3.68 3.13 3.49 2.88 3.68 3.65 3.56 3.46 3.44 0.29
VO2 (L/min) 0.25 0.23 0.20 0.24 0.23 0.21 0,27 0,19 0.23 0.03
VCO2 (L/min) 0.21 0.20 0.17 0.19 0.18 0.17 0.22 0.15 0.19 0.02
Me (g/min) 0.18 0.16 0.14 0,16 0.15 0.13 0.17 0.13 0.15 0.02
Aerobic Exercise Countermeasure
Subject 1 2 3 4 5 6 7 8 Mean SD
VO2 (mL/kg/min) 27.40 23.60 20.50 22.00 26.20 26.10 25.60 19.20 23.83 2.99
VO2 (L/min) 1.89 1.73 1.15 1.81 1.61 1.48 1.96 1.08 1.59 0.33
VCO2 (L/min) 1.92 1.79 1.14 1.87 1.65 1.54 2.00 1.04 1.62 0.36
Me (g/min) 1.34 1.21 0.80 1.22 1.06 0.89 1.21 0.74 1.06 0.22
Submaximal Exercise Test
Subject 1 2 3 4 5 6 7 8 Mean SD
VO2 (mL/kg/min) 23.65 20.43 16.38 19.14 21.51 23.00 21.30 16.99 20.30 2.64
VO2 (L/min) 1.65 1.50 0.94 1.62 1.33 1.31 1.62 0.96 1.37 0.29
VCO2 (L/min) 1.66 1.54 0.97 1.61 1.38 1.39 1.68 0.90 1.39 0.30
Me (g/min) 1.04 0.94 0.55 0.97 0.92 0.89 1.02 0.59 0.87 0.19
._ _•i_
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NAME:
Heart Watch #
Heart Watch File #
Time of Day
Approx. Temp. (°F)
Activity Type
Duration (min)
Exercise Weight/Reps
APPENDIX L
Pre- and In-Chamber Exercise Log
DATE:
Aerobic Exercise Log
Resistance Exercise Log
Weight/Reps Weight/Reps Weight/Reps Weight/Reps
Rate the difficulty of effort on a scale of 1-10 (1 being light, 10 being greatest) of your exercise
regime. Aerobic Exercise Resistance Exercise
What are your general perceptions of the exercise you performed today?
Bone Metabolism Questionnaire
Did you lift 10 lbs. (4.5 kg) or greater today? __ yes no
• ;: ?'i
ii
lbs/kg # lifts height distance carried
Did you climb stairs today? __ yes
Approximate number of steps up:
Approximate distance walked at normal pace:
58
no
Number of steps down:
rapid pace:
APPENDIX M
Post-Chamber Exercise Countermeasures Demonstration Project Debrief
• / LMLSTP Exercise Countermeasures
Demonstration Project Debrief
i
/
Thank you for your participation in this debrief and in this demonstration project.
Your efforts, comments, and suggestions are greatly appreciated.
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Post-Chamber Exercise Countermeasures Demonstration Project Debrief
Name:
LMLSTP Exercise Countermeasures Demonstration Project Debrief
A. Pre-Chamber Exercise
1. Briefly describe your normal exercise regimen before entering the chamber (type of exercise,
frequency, and duration):
i:
.
exercise regimen prior to entering the chamber:
BI
.
On a scale of 1-10 (1 being the easiest, 10 being the hardest), rate the intensity of your
Aerobic Exercise Resistance Exercise
In-Chamber Exercise
Briefly describe your perceptions of the exercise regimen prescribed in relation to the
exercise you normally performed prior to entering the chamber (same, easier, harder):
. Briefly describe positive effects you experienced from performing
a. Aerobic exercise:
b. Resistance exercise:
ii:__ i_
_ii_!
° Briefly describe any detrimental effects you experienced from performing
a. Aerobic exercise:
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b. Resistance exercise:
i) 3j
!?i
,
exercise regimen during the chamber run:
a. Beginning of Study
Aerobic Exercise
bo
On a scale of 1-10 (1 being the easiest, 10 being the hardest), rate the intensity of your
Middle of Study
Aerobic Exercise
c. End of Study
,
Resistance Exercise (High)
Resistance Exercise (Medium)
__Resistance Exercise (Low)
Resistance Exercise (High)
Resistance Exercise (Medium)
Resistance Exercise (Low)
Aerobic Exercise Resistance Exercise (High)
Resistance Exercise (Medium)
Resistance Exercise (Low)
Briefly describe your perceptions of the prescribed in-chamber exercise regimen:
6. What recommendations would you make regarding this exercise prescription for future
chamber and flight studies:
C. Post-Chamber Exercise
1. Briefly describe the exercise regimen in which you plan to participate after the chamber run
(type of exercise, frequency, and duration):
, !q
!
;)
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Post-Chamber Exercise Countermeasures Demonstration Project Debrief
2. How will the exercise you performed in the chamber influence your exercise choices after the
chamber run?
3. On a scale of 1-10 (1 being the easiest, 10 being the hardest), rate the intensity of the exercise
regimen in which you plan to engage after the chamber run:
Aerobic Exercise Resistance Exercise
Do
1.
Exercise Log
Briefly describe your perceptions of the exercise log used during this demonstration project:
2. What recommendations would you make to improve this exercise log?
E. Demonstration Project Administration
1. Briefly describe your perceptions of the administration of the exercise countermeasures
demonstration project (enough information about expectations, feedback from exercise staff, etc.):
2. What recommendations would you make to improve the administration of this demonstration
project?
i
, ?i/.
i_/, _
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